Sodium Polystyrene Sulfonate
Active substance: Sodium polystyrene sulfonate
POWDER, FOR SUSPENSION · SODIUM POLYSTYRENE SULFONATE 1 g/g
United StatesActive
Marketing holder: CMP Pharma, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- SODIUM POLYSTYRENE SULFONATE · 1 g/g
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208d-2256-7c29-a34f-d559ad6752fd,01a1208e-3cb5-744d-9b64-578066a13ef8,01a1208f-8767-757d-97f2-3e9758f67338,01a12090-6eec-7a5b-9dd2-1d43299c1337,01a12091-7cd0-7f0a-b75a-f8cb3b0b9863;count=16 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 46287-012
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL, RECTAL
Sources
- product · openFDA NDC · 46287-012 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 46287-012 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 46287-012 · Verified 2026-10-09 · open in source